Ledger.Open graph →
SEC Form D · filed May 14, 2024

Zenas BioPharma, Inc

Offering
$200.1M
Sold
$200.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Tomas O. Kiselak · WALTHAM, MADirectorPatricia J. Allen · WALTHAM, MADirectorJoseph O. Farmer · WALTHAM, MAExecLeon O. Moulder, Jr · WALTHAM, MAExec · DirectorHongbo O. Lu · WALTHAM, MADirectorPatrick G. Enright · WALTHAM, MADirectorJake J. Nunn · WALTHAM, MADirectorTim J. Xiao · WALTHAM, MADirectorJennifer J. Fox · WALTHAM, MAExecJames P. Boylan · WALTHAM, MADirectorTanya Z. Fischer · WALTHAM, MAExecJohn J. Orloff · WALTHAM, MADirectorPatrick G. Enright · WALTHAM, MADirectorTomas O. Kiselak · WALTHAM, MADirectorPatricia J. Allen · WALTHAM, MADirectorJoseph O. Farmer · WALTHAM, MAExecLeon O. Moulder, Jr · Lexington, MAExec · DirectorJake J. Nunn · WALTHAM, MADirectorTim J. Xiao · WALTHAM, MADirectorJennifer J. Fox · WALTHAM, MAExecJames P. Boylan · WALTHAM, MADirectorTanya Z. Fischer · WALTHAM, MAExecJohn J. Orloff · WALTHAM, MADirectorHongbo O. Lu · WALTHAM, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗